Biodegradation of different synthetic hydrogels made of polyethylene glycol hydrogel/RGD-peptide modifications: an immunohistochemical study in rats.
OBJECTIVE
The aim of the present study was to investigate the pattern of biodegradation of different polyethylene glycol (PEG) hydrogel/RGD-peptide modifications in rats.


METHODS
Two different hydrogels were employed: (i) a combination of four-arm PEG-thiol, M(n)=2.3 kDa, and eight-arm PEG-acrylate, M(n)=2.3 kDa (PEG1); and (ii) a combination of four-arm PEG-thiol, M(n)=2.3 kDa, and four-arm PEG-acrylate, M(n)=15 kDa (PEG2). Both PEG1 and PEG2 were either used alone or combined with a nine amino acid cys-RGD peptide (RGD). A non-cross-linked porcine type I and III collagen membrane [BioGide (BG)] served as control. Specimens were randomly allocated in unconnected subcutaneous pouches separated surgically on the back of 60 wistar rats, which were divided into six groups (1, 2, 4, 8, 16, and 24 weeks). Specimens were prepared for histological (tissue integration, foreign body reactions, biodegradation) and immunohistochemical (angiogenesis) analysis.


RESULTS
All materials investigated revealed unimpeded and comparable tissue integration without any signs of foreign body reactions. While BG exhibited transmembraneous blood vessel formation at 1 week, all PEG specimens were just surrounded by a well-vascularized connective tissue. The hydrolytic disruption of PEG1 and PEG1/RGD specimens was associated with an ingrowth of blood vessels at 4 weeks. Biodegradation times were highest for PEG1 (24 weeks)>PEG1/RGD (16 weeks)>BG (4 weeks)>PEG2=PEG2/RGD (2 weeks).


CONCLUSIONS
Within the limits of the present study, it was concluded that (i) all materials investigated revealed a high biocompatibility and tissue integration, and (ii) hydrogel biodegradation was dependent on PEG composition.
Herten
Monika
M
Department of Oral Surgery, Heinrich Heine University, Düsseldorf, Germany.
Jung
Ronald E
RE
Ferrari
Daniel
D
Rothamel
Daniel
D
Golubovic
Vladimir
V
Molenberg
Aart
A
Hämmerle
Christoph H F
CH
Becker
Jürgen
J
Schwarz
Frank
F
D020341:Absorbable Implants; D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry*; D003094:Collagen / Q000737:chemistry; D024042:Collagen Type I / Q000737:chemistry; D024061:Collagen Type III / Q000737:chemistry; D003238:Connective Tissue / Q000473:pathology; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate / Q000737:chemistry*; D007150:Immunohistochemistry; D008567:Membranes, Artificial; D018919:Neovascularization, Physiologic / Q000502:physiology; D009842:Oligopeptides / Q000737:chemistry*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D012867:Skin / Q000473:pathology; D012995:Solubility; D040521:Subcutaneous Tissue / Q000473:pathology; D013499:Surface Properties; D013997:Time Factors
C106416:Bio-Gide; D001672:Biocompatible Materials; D024042:Collagen Type I; D024061:Collagen Type III; D008567:Membranes, Artificial; D009842:Oligopeptides; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; C047981:arginyl-glycyl-aspartic acid; D003094:Collagen